StockNews.com assumed coverage on shares of Arcadia Biosciences (NASDAQ:RKDA – Free Report) in a report published on Wednesday. The firm issued a sell rating on the basic materials company’s stock.
Arcadia Biosciences Stock Down 0.7 %
Shares of RKDA opened at $6.11 on Wednesday. The business has a 50-day simple moving average of $4.40 and a two-hundred day simple moving average of $3.43. Arcadia Biosciences has a 12-month low of $1.85 and a 12-month high of $10.31. The stock has a market cap of $8.34 million, a PE ratio of -1.43 and a beta of 1.18.
Arcadia Biosciences Company Profile
Read More
- Five stocks we like better than Arcadia Biosciences
- What is the Australian Securities Exchange (ASX)
- S&P 500 ETFs: Expense Ratios That Can Boost Your Long-Term Gains
- 3 Warren Buffett Stocks to Buy Now
- How AI Implementation Could Help MongoDB Roar Back in 2025
- 3 Small Caps With Big Return Potential
- Hedge Funds Boost Oil Positions: Is a Major Rally on the Horizon?
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.